Hyperbaric oxygen therapy (HBOT )can improve the effectiveness of adalimumab in hidradenitis suppurativa

G Ital Dermatol Venereol. 2020 Apr;155(2):234-235. doi: 10.23736/S0392-0488.18.05913-8. Epub 2018 Apr 19.

Authors

Claudio Marasca¹, Giovanni Vivona², Maria Carmela Annunziata³, Sara Cacciapuoti³, Emilia Capasso², Alessandra Ciotola², Gianmarco Russo², Gabriella Fabbrocini³

Affiliations

¹ Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy - [email protected].
² Section of Anesthesiology and Intensive Care, Department of Nephrology, Urology, General Surgery, Kidney Transplant Surgery, Anesthesiology and Intensive Care, Federico II University, Naples, Italy.
³ Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

PMID: 29683280
DOI: 10.23736/S0392-0488.18.05913-8

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / administration & dosage*
Aged
Anti-Inflammatory Agents / administration & dosage
Combined Modality Therapy
Hidradenitis Suppurativa / pathology
Hidradenitis Suppurativa / therapy*
Humans
Hyperbaric Oxygenation / methods*
Male
Treatment Outcome

Substances

Anti-Inflammatory Agents
Adalimumab